May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Selenium Effects on Metalloproteinase Activity in Trabecular Meshwork Cell Supernatants
Author Affiliations & Notes
  • R.L. Bruhn
    Epidemiology and Ophthalmology, University Arizona, Tucson, AZ, United States
  • S.M. Conley
    Pharmacology and Toxicology, University Arizona, Tucson, AZ, United States
  • P.V. Morgan
    Ophthalmology, University Arizona, Tucson, AZ, United States
  • W.D. Stamer
    Ophthalmology, University Arizona, Tucson, AZ, United States
  • Footnotes
    Commercial Relationships  R.L. Bruhn, None; S.M. Conley, None; P.V. Morgan, None; W.D. Stamer, None.
  • Footnotes
    Support  Research to Prevent Blindness and a Grant from Mr. and Mrs. Polak
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1173. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.L. Bruhn, S.M. Conley, P.V. Morgan, W.D. Stamer; Selenium Effects on Metalloproteinase Activity in Trabecular Meshwork Cell Supernatants . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1173.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: A current selenium-supplementation intervention trial (the Nutritional Prevention of Cancer), based here at the University of Arizona, has seen an increased incidence of glaucoma as shown by an elevated hazard ratio (HR = 1.31;95% Confidence Interval =0.74-2.34) in the selenium-supplemented group. Since selenium has been shown to directly inhibit matrix metalloproteinases (MMPs) and elevate tissue inhibitors of metalloproteinases (TIMPs) in various types of cultured cells, the purpose of this study was to determine the effect of selenium on matrix metalloproteinase turnover in human trabecular meshwork (HTM) cells; a site of pathology in glaucoma. Methods: HTM cell cultures were dosed with the selenium compound, methylseleninic acid (MeSA), to determine the effects of selenium on MMP activity and MMP and TIMP secretion in vitro. Cells were exposed to 100 nM or 1 µM MeSA for 24 hours in serum free medium. Supernatants were collected, concentrated, and analyzed by zymography or by western blotting using monoclonal antibodies to MMP-2, MMP-9, TIMP-1, and TIMP-2. Results: Secretion of TIMP-1 appeared to decrease with increasing concentrations of MeSA (n=11). Limited analyses of TIMP-2 showed either no net change in overall protein secretion, or a slight increase in protein secretion (n=2). MMP-9 was not detectable by zymography or western blotting. We observed consistent increases in the appearance of the active form of MMP-2 (n=2), while overall appearance of the inactive form remained unchanged (n=11). MMP-2 zymography results showed that treatment with MeSA did not change the gelatinase activity of MMP-2 (inactive form, n=7), however the gelatinase activity of the active form of MMP-2 consistently decreased after treatment (n=5). Conclusion: These results are consistent with previously published studies of selenium's action on MMP-2 in cultures of human umbilical vein endothelial cells. The action of MeSA on secreted MMPs and TIMPs from HTM cells suggests a possible mechanism for selenium-induced increases in intraocular pressure and thus a possible mode of action for selenium-induced glaucoma.

Keywords: trabecular meshwork • enzymes/enzyme inhibitors • extracellular matrix 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.